false
--12-31
Q2
0001080340
0001080340
2025-01-01
2025-06-30
0001080340
2025-07-22
0001080340
2025-06-30
0001080340
2024-12-31
0001080340
2025-04-01
2025-06-30
0001080340
2024-04-01
2024-06-30
0001080340
2024-01-01
2024-06-30
0001080340
us-gaap:CommonStockMember
2025-03-31
0001080340
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
0001080340
us-gaap:TreasuryStockCommonMember
2025-03-31
0001080340
us-gaap:RetainedEarningsMember
2025-03-31
0001080340
2025-03-31
0001080340
us-gaap:CommonStockMember
2024-03-31
0001080340
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001080340
us-gaap:TreasuryStockCommonMember
2024-03-31
0001080340
us-gaap:RetainedEarningsMember
2024-03-31
0001080340
2024-03-31
0001080340
us-gaap:CommonStockMember
2024-12-31
0001080340
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0001080340
us-gaap:TreasuryStockCommonMember
2024-12-31
0001080340
us-gaap:RetainedEarningsMember
2024-12-31
0001080340
us-gaap:CommonStockMember
2023-12-31
0001080340
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001080340
us-gaap:TreasuryStockCommonMember
2023-12-31
0001080340
us-gaap:RetainedEarningsMember
2023-12-31
0001080340
2023-12-31
0001080340
us-gaap:CommonStockMember
2025-04-01
2025-06-30
0001080340
us-gaap:AdditionalPaidInCapitalMember
2025-04-01
2025-06-30
0001080340
us-gaap:TreasuryStockCommonMember
2025-04-01
2025-06-30
0001080340
us-gaap:RetainedEarningsMember
2025-04-01
2025-06-30
0001080340
us-gaap:CommonStockMember
2024-04-01
2024-06-30
0001080340
us-gaap:AdditionalPaidInCapitalMember
2024-04-01
2024-06-30
0001080340
us-gaap:TreasuryStockCommonMember
2024-04-01
2024-06-30
0001080340
us-gaap:RetainedEarningsMember
2024-04-01
2024-06-30
0001080340
us-gaap:CommonStockMember
2025-01-01
2025-06-30
0001080340
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-06-30
0001080340
us-gaap:TreasuryStockCommonMember
2025-01-01
2025-06-30
0001080340
us-gaap:RetainedEarningsMember
2025-01-01
2025-06-30
0001080340
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001080340
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-06-30
0001080340
us-gaap:TreasuryStockCommonMember
2024-01-01
2024-06-30
0001080340
us-gaap:RetainedEarningsMember
2024-01-01
2024-06-30
0001080340
us-gaap:CommonStockMember
2025-06-30
0001080340
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0001080340
us-gaap:TreasuryStockCommonMember
2025-06-30
0001080340
us-gaap:RetainedEarningsMember
2025-06-30
0001080340
us-gaap:CommonStockMember
2024-06-30
0001080340
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001080340
us-gaap:TreasuryStockCommonMember
2024-06-30
0001080340
us-gaap:RetainedEarningsMember
2024-06-30
0001080340
2024-06-30
0001080340
2024-01-01
2024-12-31
0001080340
us-gaap:ConstructionLoansMember
2025-06-30
0001080340
LOAN:OriginallyDueInTwoThousandAndSixteenMember
2025-06-30
0001080340
LOAN:OriginallyDueInTwoThousandAndTwentyMember
2025-06-30
0001080340
LOAN:OriginallyDueInTwoThousandAndTwentyTwoMember
2025-06-30
0001080340
LOAN:OriginallyDueInTwoThousandAndTwentyThreeMember
2025-06-30
0001080340
LOAN:OriginallyDueInTwoThousandAndTwentyFourMember
2025-06-30
0001080340
LOAN:OriginallyDueInFirstSixMonthsOfTwoThousandTwentyFiveMember
2025-06-30
0001080340
us-gaap:SubsequentEventMember
2025-07-01
2025-07-01
0001080340
LOAN:DevelopersResidentialMember
2025-06-30
0001080340
LOAN:DevelopersCommercialMember
2025-06-30
0001080340
LOAN:DevelopersMixedUsedMember
2025-06-30
0001080340
LOAN:DevelopersResidentialMember
2024-12-31
0001080340
LOAN:DevelopersCommercialMember
2024-12-31
0001080340
LOAN:DevelopersMixedUsedMember
2024-12-31
0001080340
LOAN:WebsterCreditLineMember
2025-06-30
0001080340
LOAN:WebsterCreditLineMember
2025-01-01
2025-06-30
0001080340
LOAN:WebsterCreditLineMember
LOAN:AmendedAndRestatedCreditAgreementMember
2025-06-30
0001080340
LOAN:SeniorSecuredNotesMember
LOAN:IndentureMember
2016-04-25
0001080340
LOAN:SeniorSecuredNotesMember
LOAN:IndentureMember
2016-04-25
2016-04-25
0001080340
LOAN:SeniorSecuredNotesMember
2016-04-25
0001080340
LOAN:MBCFundingIIMember
2016-04-25
2016-04-25
0001080340
LOAN:MBCFundingIIMember
2016-04-25
0001080340
LOAN:MBCFundingIIMember
LOAN:ChangeOfControlMember
2016-04-25
2016-04-25
0001080340
LOAN:MrRanMember
2025-06-30
0001080340
LOAN:MrKaoMember
2025-06-30
0001080340
srt:ChiefExecutiveOfficerMember
2011-09-09
2011-09-09
0001080340
srt:MaximumMember
us-gaap:CommonStockMember
2023-04-11
2023-04-11
0001080340
us-gaap:CommonStockMember
2023-04-11
2024-04-10
0001080340
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001080340
LOAN:O2025Q2DividendsMember
2025-04-17
2025-04-17
0001080340
LOAN:O2025Q2DividendsMember
2025-04-17
0001080340
us-gaap:SubsequentEventMember
LOAN:O2025Q2DividendsMember
2025-07-15
2025-07-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
LOAN:Integer
xbrli:pure
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
☒ QUARTERLY REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended June 30, 2025
or
☐ TRANSITION REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from _______________________________ to _________________________________
Commission
File Number: 000-25991
MANHATTAN
BRIDGE CAPITAL, INC.
(Exact
name of registrant as specified in its charter)
New
York |
|
11-3474831 |
(State
or other jurisdiction
of incorporation or organization) |
|
(I.R.S.
Employer
Identification No.) |
60
Cutter Mill Road, Great Neck, New York 11021
(Address
of principal executive offices)
(516)
444-3400
(Registrant’s
telephone number, including area code)
(Former
name, former address and former fiscal year, if changed since last report)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
shares, par value $.001 |
|
LOAN |
|
Nasdaq
Capital Market |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). ☒ Yes ☐ No
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large
accelerated filer |
☐ |
Accelerated
filer |
☐ |
|
Non-accelerated
filer |
☒ |
Smaller
reporting company |
☒ |
|
Emerging
growth company |
☐ |
|
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No
As
of July 22, 2025, the registrant had a total of 11,438,651 common shares, $.001 par value per share, outstanding.
MANHATTAN
BRIDGE CAPITAL, INC.
TABLE
OF CONTENTS
|
|
Page
Number |
Part I |
FINANCIAL INFORMATION |
|
|
|
|
Item
1. |
Condensed Consolidated Financial Statements (unaudited) |
2 |
|
|
|
|
Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024 (Audited) |
2 |
|
|
|
|
Consolidated Statements of Operations for the Three and Six Month Periods Ended June 30, 2025 and 2024 |
3 |
|
|
|
|
Consolidated Statements of Changes in Stockholders’ Equity for the Three and Six Month Periods Ended June 30, 2025 and 2024 |
4 |
|
|
|
|
Consolidated Statements of Cash Flows for the Six Month Periods Ended June 30, 2025 and 2024 |
5 |
|
|
|
|
Notes to Condensed Consolidated Financial Statements |
6 |
|
|
|
Item
2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
10 |
|
|
|
Item
3. |
Quantitative and Qualitative Disclosures about Market Risk |
14 |
|
|
|
Item
4. |
Controls and Procedures |
14 |
|
|
|
Part II |
OTHER INFORMATION |
|
|
|
|
Item
6. |
Exhibits |
15 |
|
|
|
SIGNATURES |
16 |
|
|
EXHIBITS |
|
Forward
Looking Statements
This
report contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”). Forward-looking statements are typically identified by the words “believe,” “expect,”
“intend,” “estimate” and similar expressions. Those statements appear in a number of places in this report and
include statements regarding our intent, belief or current expectations or those of our directors or officers with respect to, among
other things, trends affecting our financial condition and results of operations and our business and growth strategies. These forward-looking
statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those
projected, expressed or implied in the forward-looking statements as a result of various factors (such factors are referred to herein
as “Cautionary Statements”), including but not limited to the following: (i) our loan origination activities, revenues and
profits are limited by available funds; (ii) we operate in a highly competitive market and competition may limit our ability to originate
loans with favorable interest rates; (iii) our Chief Executive Officer is critical to our business and our future success may depend
on our ability to retain him; (iv) if we overestimate the yields on our loans or incorrectly value the collateral securing the loan,
we may experience losses; (v) we may be subject to “lender liability” claims; (vi) our due diligence may not uncover all
of a borrower’s liabilities or other risks to its business; (vii) borrower concentration could lead to significant losses; (viii)
we may choose to make distributions in our own stock, in which case you may be required to pay income taxes in excess of the cash dividends
you receive; (ix) an increase in interest rates may impact our profitability; (x) we may be unsuccessful in our efforts to extend or
replace the Webster Credit Line (as defined below); and (xi) we may be unsuccessful in our efforts to refinance our 6% senior secured
notes, due April 22, 2026 (the “Notes”). The accompanying information contained in this report, including the information
set forth under “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” identifies
important factors that could cause such differences. Further information on potential factors that could affect our business is described
under the heading “Risk Factors” in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December
31, 2024. These forward-looking statements speak only as of the date of this report, and we caution potential investors not to place
undue reliance on such statements. We undertake no obligation to update or revise any forward-looking statements. All subsequent written
or oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the
Cautionary Statements.
All
references in this Form 10-Q to “Company,” “we,” “us,” or “our” refer to Manhattan Bridge
Capital, Inc. and its wholly-owned subsidiary, MBC Funding II Corp., unless the context otherwise indicates.
PART
I. FINANCIAL INFORMATION
Item
1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
MANHATTAN
BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED
BALANCE SHEETS
| |
June 30,
2025 | | |
December 31, 2024 | |
| |
(unaudited) | | |
(audited) | |
Assets | |
| | | |
| | |
Loans receivable, net of deferred origination and other fees | |
$ | 65,217,737 | | |
$ | 65,405,731 | |
Interest and other fees receivable on loans | |
| 1,877,218 | | |
| 1,521,033 | |
Cash | |
| 208,767 | | |
| 178,012 | |
Cash – restricted | |
| 875 | | |
| 23,750 | |
Other assets | |
| 153,112 | | |
| 62,080 | |
Right-of-use asset – operating lease, net | |
| 127,633 | | |
| 154,039 | |
Deferred financing costs, net | |
| 9,240 | | |
| 16,171 | |
Total assets | |
$ | 67,594,582 | | |
$ | 67,360,816 | |
| |
| | | |
| | |
Liabilities and Stockholders’ Equity | |
| | | |
| | |
Liabilities: | |
| | | |
| | |
Line of credit | |
$ | 16,523,205 | | |
$ | 16,427,874 | |
Senior secured notes (net of deferred financing costs of $59,443 and $96,985, respectively) | |
| 5,940,557 | | |
| 5,903,015 | |
Accounts payable and accrued expenses | |
| 198,622 | | |
| 232,236 | |
Operating lease liability | |
| 139,882 | | |
| 167,119 | |
Loan holdback | |
| 50,000 | | |
| 50,000 | |
Dividends payable | |
| 1,315,445 | | |
| 1,315,445 | |
Total liabilities | |
| 24,167,711 | | |
| 24,095,689 | |
| |
| | | |
| | |
Commitments and contingencies | |
| - | | |
| | |
| |
| | | |
| | |
Stockholders’ equity: | |
| | | |
| | |
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued and outstanding | |
| — | | |
| — | |
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,438,651 outstanding | |
| 11,757 | | |
| 11,757 | |
Additional paid-in capital | |
| 45,568,473 | | |
| 45,561,941 | |
Less: Treasury stock, at cost – 318,407 shares | |
| (1,070,406 | ) | |
| (1,070,406 | ) |
Accumulated deficit | |
| (1,082,953 | ) | |
| (1,238,165 | ) |
Total stockholders’ equity | |
| 43,426,871 | | |
| 43,265,127 | |
Total liabilities and stockholders’ equity | |
$ | 67,594,582 | | |
$ | 67,360,816 | |
The
accompanying notes are an integral part of these condensed consolidated financial statements.
MANHATTAN
BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED
STATEMENTS OF OPERATIONS
(unaudited)
| |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| |
Three Months
Ended June 30, | | |
Six Months
Ended June 30, | |
| |
2025 | | |
2024 | | |
2025 | | |
2024 | |
Revenue: | |
| | | |
| | | |
| | | |
| | |
Interest income from loans | |
$ | 1,899,403 | | |
$ | 2,032,687 | | |
$ | 3,733,317 | | |
$ | 4,175,174 | |
Origination fees | |
| 455,833 | | |
| 410,528 | | |
| 895,632 | | |
| 841,119 | |
Total revenue | |
| 2,355,236 | | |
| 2,443,215 | | |
| 4,628,949 | | |
| 5,016,293 | |
| |
| | | |
| | | |
| | | |
| | |
Operating costs and expenses: | |
| | | |
| | | |
| | | |
| | |
Interest and amortization of deferred financing costs | |
| 506,250 | | |
| 603,230 | | |
| 957,615 | | |
| 1,293,819 | |
Referral fees | |
| 1,523 | | |
| 500 | | |
| 1,667 | | |
| 1,000 | |
General and administrative expenses | |
| 437,785 | | |
| 434,282 | | |
| 891,355 | | |
| 844,560 | |
Total operating costs and expenses | |
| 945,558 | | |
| 1,038,012 | | |
| 1,850,637 | | |
| 2,139,379 | |
Income from operations | |
| 1,409,678 | | |
| 1,405,203 | | |
| 2,778,312 | | |
| 2,876,914 | |
Other income | |
| 4,500 | | |
| 4,500 | | |
| 9,000 | | |
| 9,000 | |
Income tax expense | |
| (1,210 | ) | |
| (650 | ) | |
| (1,210 | ) | |
| (650 | ) |
Net income | |
$ | 1,412,968 | | |
$ | 1,409,053 | | |
$ | 2,786,102 | | |
$ | 2,885,264 | |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted net income per common share outstanding: | |
| | | |
| | | |
| | | |
| | |
—Basic | |
$ | 0.12 | | |
$ | 0.12 | | |
$ | 0.24 | | |
$ | 0.25 | |
—Diluted | |
$ | 0.12 | | |
$ | 0.12 | | |
$ | 0.24 | | |
$ | 0.25 | |
| |
| | | |
| | | |
| | | |
| | |
Weighted average number of common shares outstanding: | |
| | | |
| | | |
| | | |
| | |
—Basic | |
| 11,438,651 | | |
| 11,438,651 | | |
| 11,438,651 | | |
| 11,438,662 | |
—Diluted | |
| 11,438,651 | | |
| 11,438,651 | | |
| 11,438,651 | | |
| 11,438,662 | |
The
accompanying notes are an integral part of these condensed consolidated financial statements.
MANHATTAN
BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(unaudited)
FOR
THE THREE MONTHS ENDED JUNE 30, 2025
| |
Shares | | |
Amount | | |
in Capital | | |
Shares | | |
Cost | | |
Deficit | | |
Totals | |
| |
Common Shares | | |
Additional Paid | | |
Treasury Stock | | |
Accumulated | | |
| |
| |
Shares | | |
Amount | | |
in Capital | | |
Shares | | |
Cost | | |
Deficit | | |
Totals | |
Balance, April 1, 2025 | |
| 11,757,058 | | |
$ | 11,757 | | |
$ | 45,565,207 | | |
| 318,407 | | |
$ | (1,070,406 | ) | |
$ | (1,180,476 | ) | |
$ | 43,326,082 | |
Non-cash compensation | |
| | | |
| | | |
| 3,266 | | |
| | | |
| | | |
| | | |
| 3,266 | |
Dividends declared and payable | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (1,315,445 | ) | |
| (1,315,445 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 1,412,968 | | |
| 1,412,968 | |
Balance, June 30, 2025 | |
| 11,757,058 | | |
$ | 11,757 | | |
$ | 45,568,473 | | |
| 318,407 | | |
$ | (1,070,406 | ) | |
$ | (1,082,953 | ) | |
$ | 43,426,871 | |
FOR
THE THREE MONTHS ENDED JUNE 30, 2024
| |
Common Shares | | |
Additional Paid | | |
Treasury Stock | | |
Accumulated | | |
| |
| |
Shares | | |
Amount | | |
in Capital | | |
Shares | | |
Cost | | |
Deficit | | |
Totals | |
Balance, April 1, 2024 | |
| 11,757,058 | | |
$ | 11,757 | | |
$ | 45,552,142 | | |
| 318,407 | | |
$ | (1,070,406 | ) | |
$ | (1,406,555 | ) | |
$ | 43,086,938 | |
Non-cash compensation | |
| | | |
| | | |
| 3,266 | | |
| | | |
| | | |
| | | |
| 3,266 | |
Dividends declared and payable | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (1,315,445 | ) | |
| (1,315,445 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 1,409,053 | | |
| 1,409,053 | |
Balance, June 30, 2024 | |
| 11,757,058 | | |
$ | 11,757 | | |
$ | 45,555,408 | | |
| 318,407 | | |
$ | (1,070,406 | ) | |
$ | (1,312,947 | ) | |
$ | 43,183,812 | |
FOR
THE SIX MONTHS ENDED JUNE 30, 2025
| |
Common Shares | | |
Additional Paid | | |
Treasury Stock | | |
Accumulated | | |
| |
| |
Shares | | |
Amount | | |
in Capital | | |
Shares | | |
Cost | | |
Deficit | | |
Totals | |
Balance, January 1, 2025 | |
| 11,757,058 | | |
$ | 11,757 | | |
$ | 45,561,941 | | |
| 318,407 | | |
$ | (1,070,406 | ) | |
$ | (1,238,165 | ) | |
$ | 43,265,127 | |
Non-cash compensation | |
| | | |
| | | |
| 6,532 | | |
| | | |
| | | |
| | | |
| 6,532 | |
Dividends paid | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (1,315,445 | ) | |
| (1,315,445 | ) |
Dividends declared and payable | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (1,315,445 | ) | |
| (1,315,445 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 2,786,102 | | |
| 2,786,102 | |
Balance, June 30, 2025 | |
| 11,757,058 | | |
$ | 11,757 | | |
$ | 45,568,473 | | |
| 318,407 | | |
$ | (1,070,406 | ) | |
$ | (1,082,953 | ) | |
$ | 43,426,871 | |
FOR
THE SIX MONTHS ENDED JUNE 30, 2024
| |
Common Shares | | |
Additional Paid | | |
Treasury Stock | | |
Accumulated | | |
| |
| |
Shares | | |
Amount | | |
in Capital | | |
Shares | | |
Cost | | |
Deficit | | |
Totals | |
Balance, January 1, 2024 | |
| 11,757,058 | | |
$ | 11,757 | | |
$ | 45,548,876 | | |
| 316,407 | | |
$ | (1,060,606 | ) | |
$ | (1,567,321 | ) | |
$ | 42,932,706 | |
Balance | |
| 11,757,058 | | |
$ | 11,757 | | |
$ | 45,548,876 | | |
| 316,407 | | |
$ | (1,060,606 | ) | |
$ | (1,567,321 | ) | |
$ | 42,932,706 | |
Purchase of treasury shares | |
| | | |
| | | |
| | | |
| 2,000 | | |
| (9,800 | ) | |
| | | |
| (9,800 | ) |
Non-cash compensation | |
| | | |
| | | |
| 6,532 | | |
| | | |
| | | |
| | | |
| 6,532 | |
Dividends paid | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (1,315,445 | ) | |
| (1,315,445 | ) |
Dividends declared and payable | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (1,315,445 | ) | |
| (1,315,445 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 2,885,264 | | |
| 2,885,264 | |
Balance, June 30, 2024 | |
| 11,757,058 | | |
$ | 11,757 | | |
$ | 45,555,408 | | |
| 318,407 | | |
$ | (1,070,406 | ) | |
$ | (1,312,947 | ) | |
$ | 43,183,812 | |
Balance | |
| 11,757,058 | | |
$ | 11,757 | | |
$ | 45,555,408 | | |
| 318,407 | | |
$ | (1,070,406 | ) | |
$ | (1,312,947 | ) | |
$ | 43,183,812 | |
The
accompanying notes are an integral part of these condensed consolidated financial statements.
MANHATTAN
BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(unaudited)
| |
2025 | | |
2024 | |
| |
Six Months Ended June 30, | |
| |
2025 | | |
2024 | |
Cash flows from operating activities: | |
| | | |
| | |
Net income | |
$ | 2,786,102 | | |
$ | 2,885,264 | |
Adjustments to reconcile net income to net cash provided by operating activities - | |
| | | |
| | |
Amortization of deferred financing costs | |
| 44,473 | | |
| 44,191 | |
Adjustment to right-of-use asset - operating lease and liability | |
| (831 | ) | |
| 190 | |
Depreciation | |
| 2,790 | | |
| 2,209 | |
Non-cash compensation expense | |
| 6,532 | | |
| 6,532 | |
Changes in operating assets and liabilities: | |
| | | |
| | |
Interest and other fees receivable on loans | |
| (369,307 | ) | |
| (315,399 | ) |
Other assets | |
| (93,403 | ) | |
| (71,703 | ) |
Accounts payable and accrued expenses | |
| (33,614 | ) | |
| (53,044 | ) |
Deferred origination and other fees | |
| 64,338 | | |
| (72,992 | ) |
Net cash provided by operating activities | |
| 2,407,080 | | |
| 2,425,248 | |
| |
| | | |
| | |
Cash flows from investing activities: | |
| | | |
| | |
Issuance of short-term loans | |
| (23,482,540 | ) | |
| (19,455,000 | ) |
Collections received from loans | |
| 23,619,317 | | |
| 25,866,190 | |
Purchase of fixed assets | |
| (418 | ) | |
| (1,191 | ) |
Net cash provided by investing activities | |
| 136,359 | | |
| 6,409,999 | |
| |
| | | |
| | |
Cash flows from financing activities: | |
| | | |
| | |
Repayment of line of credit | |
| (26,365,153 | ) | |
| (27,543,007 | ) |
Proceeds from line of credit | |
| 26,460,484 | | |
| 19,736,179 | |
Dividends paid | |
| (2,630,890 | ) | |
| (2,602,518 | ) |
Purchase of treasury shares | |
| — | | |
| (9,800 | ) |
Deferred financing costs incurred | |
| — | | |
| (2,167 | ) |
Net cash used in financing activities | |
| (2,535,559 | ) | |
| (10,421,313 | ) |
| |
| | | |
| | |
Net increase (decrease) in cash | |
| 7,880 | | |
| (1,586,066 | ) |
Cash and restricted cash, beginning of period(1) | |
| 201,762 | | |
| 1,691,995 | |
Cash and restricted cash, end of period(2) | |
$ | 209,642 | | |
$ | 105,929 | |
| |
| | | |
| | |
Supplemental Disclosure of Cash Flow Information: | |
| | | |
| | |
Cash paid during the period for taxes | |
$ | 1,210 | | |
$ | 650 | |
Cash paid during the period for interest | |
$ | 903,251 | | |
$ | 1,297,587 | |
Cash paid during the period for operating leases | |
$ | 31,982 | | |
$ | 32,208 | |
| |
| | | |
| | |
Supplemental Schedule of Noncash Financing Activities: | |
| | | |
| | |
Dividend declared and payable | |
$ | 1,315,445 | | |
$ | 1,315,445 | |
| |
| | | |
| | |
Supplemental Schedule of Noncash Operating and Investing Activities: | |
| | | |
| | |
Reduction in interest receivable in connection with the increase in loans receivable | |
$ | 13,122 | | |
$ | 222,520 | |
The
accompanying notes are an integral part of these condensed consolidated financial statements.
MANHATTAN
BRIDGE CAPITAL, INC. AND SUBSIDIARY
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR
THE THREE AND SIX MONTHS ENDED JUNE 30, 2025
1.
DESCRIPTION OF THE COMPANY
The
accompanying unaudited condensed consolidated financial statements of Manhattan Bridge Capital, Inc. (“MBC”), a New York
corporation founded in 1989, and its consolidated subsidiary, MBC Funding II Corp. (“MBC Funding II”), a New York corporation
formed in December 2015 (collectively referred to herein as the “Company”) have been prepared by the Company in accordance
with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions
to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete annual audited
financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary
for a fair presentation have been included. The accompanying unaudited condensed consolidated financial statements should be read in
conjunction with the Company’s annual audited consolidated financial statements for the year ended December 31, 2024 and the notes
thereto included in the Company’s Annual Report on Form 10-K. Results of consolidated operations for the interim period are not
necessarily indicative of the operating results to be attained in the entire fiscal year.
The
Company offers short-term, secured, non–banking loans to real estate investors (also known as hard money loans) to fund their acquisition,
renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including
New Jersey and Connecticut, and in Florida.
Summary
of Significant Accounting Policies
The
preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed
consolidated financial statements and the reported amount of revenues and expenses during the reporting period. Actual amounts could
differ from those estimates.
The
condensed consolidated financial statements include the accounts of MBC and MBC Funding II. All significant intercompany balances and
transactions have been eliminated in consolidation.
Interest
income from commercial loans is recognized, as earned, over the loan period.
Loans
receivable are presented in the condensed consolidated financial statements at cost, net of deferred origination and other fees, which
are amortized over the term of the respective loan.
Certain
amounts in the consolidated financial statements for June 30, 2024 and December 31, 2024, have been reclassified to align with the presentation
for June 30, 2025.
2.
RECENTLY ISSUED TECHNICAL ACCOUNTING PRONOUNCEMENTS
Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company’s condensed consolidated financial statements.
3.
CASH – RESTRICTED
Restricted
cash mainly represents collections received, pending clearance, from the Company’s commercial loans and is primarily dedicated
to the reduction of the Webster Credit Line (as defined below), established pursuant to the Amended and Restated Credit Agreement (as
defined below, see Note 5).
4.
COMMERCIAL LOANS
Loans
Receivable
The
Company offers short-term secured non–banking loans to real estate investors (also known as hard money loans) to fund their acquisition
and construction of properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida. The loans
are principally secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers.
The loans are generally for a term of one year. The short-term loans are initially recorded, and carried thereafter, in the condensed
consolidated financial statements at cost, net of deferred origination and other fees, which totaled approximately $633,000 and $569,000
at June 30, 2025 and December 31, 2024, respectively. Most of the loans provide for receipt of interest only during the term of the loan
and a balloon payment at the end of the term. At June 30, 2025, the Company was committed to $6,286,256 in construction loans that can
be drawn by the borrowers when certain conditions are met.
At
June 30, 2025, the Company has made loans to four different entities in the aggregate amount of $7,889,500, or 12.0% of its loan portfolio.
One individual holds at least a fifty percent interest in each of the different entities. This individual is not affiliated with any
officers or directors of the Company.
The
Company generally grants loans for a term of one year. When a performing loan reaches its maturity and the borrower requests an extension,
the Company may extend the term of the loan beyond one year. Prior to granting an extension of any loan, the Company reevaluates the
underlying collateral.
Credit
Risk
Credit
risk profile based on loan activity as of June 30, 2025 and December 31, 2024:
SCHEDULE OF CREDIT RISK
Performing loans | |
Developers-
Residential | | |
Developers-
Commercial | | |
Developers-
Mixed Use | | |
Total outstanding
loans | |
June 30, 2025 | |
$ | 56,645,610 | | |
$ | 7,880,000 | | |
$ | 1,325,000 | | |
$ | 65,850,610 | |
December 31, 2024 (audited) | |
$ | 56,149,265 | | |
$ | 7,380,000 | | |
$ | 2,445,000 | | |
$ | 65,974,265 | |
At
June 30, 2025, the Company’s loans receivable consisted of loans in the amount of $10,957, $1,370,250, $2,125,000, $12,108,479
and $11,365,000, originally due or committed to lend to borrowers in 2016, 2020, 2022, 2023 and 2024, respectively. The loans receivable
also include loans in the amount of $12,708,765 originally due in the first six months of 2025.
Generally,
borrowers are paying their interest, and the Company receives a fee in connection with the extension of the loans. In all instances,
the borrowers have either signed an extension agreement or are in the process of signing an extension. Accordingly, at June 30, 2025,
no loan impairments exist and there are no provisions for impairment credit losses of loans or recoveries thereof.
Subsequent
to the balance sheet date, approximately $1,480,000
of the loans receivable at June 30, 2025, were paid down or paid off, including approximately $726,000
originally due on or before June 30, 2025.
5.
LINE OF CREDIT
The
Company executed an Amended and Restated Credit and Security Agreement (as amended, the “Amended and Restated Credit Agreement”),
with Webster Business Credit Corporation (“Webster”), Flushing Bank (“Flushing”) and Mizrahi Tefahot Bank Ltd
(“Mizrahi” and together with Webster and Flushing, the “Lenders”), which established the Company’s credit
line (the “Webster Credit Line”). Currently, the Webster Credit Line provides the Company with a credit line of $32.5 million
in the aggregate until February 28, 2026, secured by assignments of mortgages and other collateral. The interest rates relating to the
Webster Credit Line equal (i) the Secured Overnight Financing Rate (“SOFR”) plus a premium, which rate aggregated approximately
7.9%, including a 0.5% agency fee, as of June 30, 2025, or (ii) a Base Rate (as defined in the Amended and Restated Credit Agreement)
plus 2.00% and a 0.5% agency fee, as chosen by the Company for each drawdown. The Company does not believe there will be any issues in
extending the Webster Credit Line or securing a similar line from another bank before its expiration.
The
Webster Credit Line contains various covenants and restrictions including, among other covenants and restrictions, limiting the amount
that the Company can borrow relative to the value of the underlying collateral, maintaining various financial ratios and limitations
on the terms of loans the Company makes to its customers, limiting the Company’s ability to pay dividends under certain circumstances,
and limiting the Company’s ability to repurchase its common shares, sell assets, engage in mergers or consolidations, grant liens,
and enter into transactions with affiliates. In addition, the Webster Credit Line contains a cross-default provision which will deem
any default under any indebtedness owed by the Company or its subsidiary, MBC Funding II, as a default under the credit line. Under the
Amended and Restated Credit Agreement, the Company may repurchase, redeem or otherwise retire its equity securities in an amount not
to exceed ten percent of the Company’s annual net income from the prior fiscal year. Further, the Company may issue up to $20 million
in bonds through its subsidiary, of which not more than $10 million of such bonds may be secured by mortgage notes receivable, and provided
that the terms and conditions of such bonds are approved by Webster, subject to its reasonable discretion. In addition, Mr. Ran has provided
a personal guaranty for the potential amounts owed under the Webster Credit line, with such guaranty not to exceed the sum of $1,000,000
plus any costs relating to the enforcement of the personal guaranty.
The
Company was in compliance with all covenants of the Webster Credit Line, as amended, as of June 30, 2025. At June 30, 2025, the outstanding
amount under the Amended Credit Agreement was $16,523,205. The interest rate on the amount outstanding fluctuates daily. The rate, including
a 0.5% agency fee, was approximately 7.9% as of June 30, 2025.
6.
SENIOR SECURED NOTES
On
April 25, 2016, in an initial public offering, MBC Funding II issued 6% senior secured notes, due April 22, 2026 (the “Notes”)
in the aggregate principal amount of $6,000,000 under the Indenture, dated April 25, 2016, among MBC Funding II, as Issuer, the Company,
as Guarantor, and Worldwide Stock Transfer LLC, as Indenture Trustee (the “Indenture”). The Notes, having a principal amount
of $1,000 each, are listed on the NYSE American and trade under the symbol “LOAN/26”. Interest accrues on the Notes commencing
on May 16, 2016. The accrued interest is payable monthly in cash, in arrears, on the 15th day of each calendar month commencing June
2016.
Under
the terms of the Indenture, the aggregate outstanding principal balance of the mortgage loans held by MBC Funding II, together with MBC
Funding II’s cash on hand, must always equal at least 120% of the aggregate outstanding principal amount of the Notes at all times.
To the extent the aggregate principal amount of the mortgage loans owned by MBC Funding II plus MBC Funding II’s cash on hand is
less than 120% of the aggregate outstanding principal balance of the Notes, MBC Funding II is required to repay, on a monthly basis,
the principal amount of the Notes equal to the amount necessary such that, after giving effect to such repayment, the aggregate principal
amount of all mortgage loans owned by MBC Funding II plus, MBC Funding II’s cash on hand at such time is equal to or greater than
120% of the outstanding principal amount of the Notes. For this purpose, each mortgage loan is deemed to have a value equal to its outstanding
principal balance, unless the borrower is in default of its obligations.
MBC
Funding II may redeem the Notes, in whole or in part, at any time after April 22, 2019, upon at least 30 days prior written notice to
the Noteholders. The redemption price will be equal to the outstanding principal amount of the Notes redeemed plus the accrued but unpaid
interest thereon up to, but not including, the date of redemption, without penalty or premium. No Notes were redeemed by MBC Funding
II as of June 30, 2025.
MBC
Funding II is obligated to offer to redeem the Notes if there occurs a “change of control” with respect to MBC Funding II
or the Company or if MBC Funding II or the Company sell any assets unless, in the case of an asset sale, the proceeds are reinvested
in the business of the seller. The redemption price in connection with a “change of control” will be 101% of the principal
amount of the Notes redeemed plus accrued but unpaid interest thereon up to, but not including, the date of redemption. The redemption
price in connection with an asset sale will be the outstanding principal amount of the Notes redeemed plus accrued but unpaid interest
thereon up to, but not including, the date of redemption.
The
Company guaranteed MBC Funding II’s obligations under the Notes, which are secured by its pledge of 100% of the outstanding common
shares of MBC Funding II that it owns. The Company plans to refinance the Notes prior to their maturity.
The
Company’s principal executive officers consist of Assaf Ran, who serves as its Chief Executive Officer and President, and Vanessa
Kao, who serves as its Chief Financial Officer. As of June 30, 2025, each of Mr. Ran and Ms. Kao owns an aggregate of $704,000 and $288,000
of our Notes, respectively.
7.
EARNINGS PER COMMON SHARE
Basic
and diluted earnings per share are calculated in accordance with Accounting Standards Codification (“ASC”) Topic 260, “Earnings
Per Share” (“ASC Topic 260”). Under ASC Topic 260, basic earnings per share is computed by dividing income available
to common shareholders by the weighted-average number of common shares outstanding for the period. The computation of diluted earnings
per share is similar to basic earnings per share, except that the denominator is increased to include the potential dilution from the
exercise of stock options and warrants for common shares using the treasury stock method. The numerator in calculating both basic and
diluted earnings per common share for each period is the reported net income.
8.
STOCK–BASED COMPENSATION
Stock-based
compensation expense recognized under ASC Topic 718, “Compensation-Stock Compensation,” for each of the three-month periods
ended June 30, 2025 and 2024 of $3,266, and for each of the six-month periods ended June 30, 2025 and 2024 of $6,532 represent the amortization
of the fair value of 1,000,000 restricted shares granted to the Company’s Chief Executive Officer on September 9, 2011 of $195,968,
after adjusting for the effect on the fair value of the stock options related to this transaction. The fair value is being amortized
over 15 years. At June 30, 2025, all 1,000,000 shares remained restricted, and the remaining unrecognized stock-based compensation amounted
to $15,242. One third of such restricted shares shall vest on each of September 9, 2026, September 9, 2027, and September 9, 2028.
9.
STOCKHOLDERS’ EQUITY
The
Company adopted a share buyback program on April 11, 2023, for the repurchase of up to 100,000 of the Company’s common shares.
Before this program expired on April 10, 2024, the Company had purchased an aggregate of 56,294 common shares at an aggregate cost of
$271,468, including 2,000 common shares repurchased during the first quarter of 2024 at an aggregate cost of $9,800.
10.
SEGMENT REPORTING
The
Company reports segment information based on the management approach which designates the internal reporting used by the Chief Operating
Decision Maker, which is the Company’s Chief Executive Officer, for making decisions and assessing performance as the source of
the Company’s reportable segments. The Company operates as a single reportable segment, originating, servicing, and managing short-term
secured commercial loans to real estate investors. Management evaluates performance on a consolidated basis, as all loans share similar
risk profiles, underwriting standards, and operational processes. Key performance metrics include interest income, origination fees,
loan performance, and operating expenses. Significant expenses reviewed by management include interest and amortization of deferred financing
costs and general and administrative expenses, which remain consistent across loan types. There are no material differences between segment-level
information and consolidated financial reporting. The Company will continue to evaluate its segment reporting disclosures and make adjustments
if there are material changes in business operations or financial reporting requirements.
Net
income from the Company’s reportable segment is as follows:
SCHEDULE
OF NET INCOME FROM THE COMPANY’S REPORTABLE SEGMENT
| |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| |
(Unaudited) | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2025 | | |
2024 | | |
2025 | | |
2024 | |
Lending revenue: | |
$ | 2,355,236 | | |
$ | 2,443,215 | | |
$ | 4,628,949 | | |
$ | 5,016,293 | |
Less: | |
| | | |
| | | |
| | | |
| | |
Interest expense | |
| 484,013 | | |
| 580,993 | | |
| 913,142 | | |
| 1,249,628 | |
Amortization of deferred financing costs | |
| 22,237 | | |
| 22,237 | | |
| 44,473 | | |
| 44,191 | |
Referral fees | |
| 1,523 | | |
| 500 | | |
| 1,667 | | |
| 1,000 | |
General and administrative expenses | |
| 437,785 | | |
| 434,282 | | |
| 891,355 | | |
| 844,560 | |
Income tax expense | |
| 1,210 | | |
| 650 | | |
| 1,210 | | |
| 650 | |
Other income | |
| (4,500 | ) | |
| (4,500 | ) | |
| (9,000 | ) | |
| (9,000 | ) |
Net income | |
$ | 1,412,968 | | |
$ | 1,409,053 | | |
$ | 2,786,102 | | |
$ | 2,885,264 | |
11.
SUBSEQUENT EVENTS
In
accordance with the dividend declared by the Company’s Board of Directors on April 17, 2025, a cash dividend of $0.115 per share
in an aggregate amount of $1,315,445 was paid on July 15, 2025, to all shareholders of record on July 8, 2025.
********
Item
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The
following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction
with our unaudited condensed consolidated financial statements and notes thereto included in this Quarterly Report on Form 10-Q. The
discussion and analysis contain forward-looking statements based on current expectations that involve risks and uncertainties.
Actual results and the timing of certain events may differ significantly from those projected in such forward-looking statements.
We
are a New York-based real estate finance company that specializes in originating, servicing and managing a portfolio of first mortgage
loans. We offer short-term, secured, non-banking loans (sometimes referred to as “hard money” loans), which we may renew
or extend on, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation
or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut,
and in Florida.
The
properties securing the loans are generally classified as residential or commercial real estate and, typically, are not income producing.
Our loans are generally secured by a first mortgage lien on real estate. In addition, each loan is personally guaranteed by the principal(s)
of the borrower, which guarantee may be collaterally secured by a pledge of the guarantor’s interest in the borrower. The face
amount of the loans we originated in the past seven years ranged from $40,000 to a maximum of $3.6 million. Our lending policy limits
the maximum amount of any loan to the lower of (i) 9.9% of the aggregate amount of our loan portfolio (not including the loan under consideration)
and (ii) $4 million. Our loans typically have a maximum initial term of 12 months and bear interest at a fixed rate of 9% to 12% per
year, except for one loan issued in June 2024, which had an initial interest rate of 11.5% that was reduced to 7.25% on January 2, 2025,
for a period of up to one year. In addition, we usually receive origination fees or “points” ranging from 0% to 2% of the
original principal amount of the loan as well as other fees relating to underwriting and funding the loan. Interest is always payable
monthly, in arrears. In the case of acquisition financing, the principal amount of the loan usually does not exceed 75% of the value
of the property (as determined by an independent appraiser) and in the case of construction financing, it is typically up to 80% of construction
costs.
Since
commencing our business in 2007, except as set forth below, we have never foreclosed on a property, although sometimes we have renewed
or extended the term of a loan to enable the borrower to avoid premature sale or refinancing of the property. When we renew or extend
a loan, we generally receive additional “points” and other fees. In June 2023, we filed a foreclosure lawsuit relating to
one property, as a result of a deed transfer from the borrower to a buyer without our consent. In that instance, the buyer of the property
on which we had a valid mortgage suffered a data breach which resulted in the failure of the buyer to remit the funds needed for the
loan payoff. In October 2023, we received the entire payoff amount for the loan receivable, including all unpaid fees, to rectify the
situation.
Our
primary business objective is to grow our loan portfolio while protecting and preserving capital in a manner that provides for attractive
risk-adjusted returns to our shareholders over the long term through dividends. We intend to achieve this objective by continuing to
selectively originate, fund loans secured by first mortgages on residential and commercial real estate held for investment located in
the New York metropolitan area, including New Jersey and Connecticut, and in Florida, and to carefully manage and service our portfolio
in a manner designed to generate attractive risk-adjusted returns across a variety of market conditions and economic cycles. We believe
that current market dynamics specifically the demand/supply imbalance for relatively small real estate loans, presents opportunities
for us to selectively originate high-quality first mortgage loans and we believe that these market conditions should persist for a number
of years. We have built our business on a foundation of intimate knowledge of the New York metropolitan area real estate market combined
with a disciplined credit and due diligence culture that is designed to protect and preserve capital. We believe that our flexibility
and ability to structure loans that address the needs of our borrowers without compromising our standards on credit risk, our expertise,
our intimate knowledge of the New York metropolitan area real estate market and our focus on newly originated first mortgage loans, has
defined our success until now and should enable us to continue to achieve our objectives.
A
principal source of new transactions has been repeat business from prior customers and their referral of new business. We also receive
leads for new business from banks, brokers and a limited amount of advertising. Finally, our Chief Executive Officer also spends a significant
portion of his time on new business development. We rely on our own employees, independent legal counsel, and other independent professionals
to verify titles and ownership, to file liens and to consummate the transactions. Outside appraisers are used to assist us in evaluating
the worth of collateral, when deemed necessary by management. We also use construction inspectors.
For
the six month periods ended June 30, 2025 and 2024, the total amounts of $23,495,662 and $19,677,520, respectively, have been lent, offset
by collections received from borrowers, under our commercial loans of $23,619,317 and $25,866,190, respectively.
At
June 30, 2025, we were committed to $6,286,256 in construction loans that can be drawn by our borrowers when certain conditions are met.
To
date, none of the loans previously made have been non-collectable, although no assurances can be given that existing or future loans
may not prove to be non-collectible or foreclosed in the future.
We
satisfied all of the requirements to be taxed as a real estate investment trust (“REIT”) and elected to be taxed as a REIT
commencing with our taxable year ended December 31, 2014. In order to maintain our qualification for taxation as a REIT and avoid any
excise tax on our net taxable income, we are required to distribute each year at least 90% of our REIT taxable income. If we distribute
less than 100% of our taxable income (but more than 90%), the undistributed portion will be taxed at the regular corporate income tax
rates. As a REIT, we may also be subject to federal excise taxes and minimum state taxes.
Results
of Operations
Three
months ended June 30, 2025 compared to three months ended June 30, 2024
Total
revenue
Total
revenues for the three months ended June 30, 2025 were approximately $2,355,000 compared to approximately $2,443,000 for the three months
ended June 30, 2024, a decrease of $88,000, or 3.6%. The decrease in revenue was primarily attributable to lower interest income, resulting
from a reduction in loans receivable, period-over-period, partially offset by an increase of origination fees. For the three months ended
June 30, 2025 and 2024, approximately $1,899,000 and $2,033,000, respectively, of our revenues were attributable to interest income on
secured commercial loans that we offer to real estate investors, and approximately $456,000 and $411,000, respectively, of our revenues
were attributable to origination fees on such loans. The loans are principally secured by collateral consisting of real estate and accompanied
by personal guarantees from the principals of the borrowers.
Interest
and amortization of deferred financing costs
Interest
and amortization of deferred financing costs for the three months ended June 30, 2025 were approximately $506,000 compared to approximately
$603,000 for the three months ended June 30, 2024, a decrease of $97,000, or 16.1%. The decrease is primarily attributable to the decrease
in interest expense due to lower SOFR rates and a reduction in borrowed amounts related to the use of the Webster Credit Line (See Note
5 to the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q).
General
and administrative expenses
General
and administrative expenses for the three months ended June 30, 2025 were approximately $438,000 compared to approximately $434,000 for
the three months ended June 30, 2024, an increase of $4,000. The increase is primarily attributable to increases in payroll expense and
NYSE American listing fee, partially offset by a reduction in legal fees as well as costs related to the filing of our registration statement
on Form S-3 incurred in 2024.
Net
income
Net
income for the three months ended June 30, 2025 was approximately $1,413,000 compared to approximately $1,409,000 for the three months
ended June 30, 2024, an increase of $4,000. The difference between periods was nominal.
Six
months ended June 30, 2025 compared to six months ended June 30, 2024
Total
revenue
Total
revenues for the six months ended June 30, 2025 were approximately $4,629,000 compared to approximately $5,016,000 for the six months
ended June 30, 2024, a decrease of $387,000, or 7.7%. The decrease in revenue was primarily attributable to lower interest income, resulting
from a reduction in loans receivable, period-over-period. For the six months ended June 30, 2025 and 2024, revenues of approximately
$3,733,000 and $4,175,000, respectively, were attributable to interest income on secured commercial loans that we offer to real estate
investors, and approximately $896,000 and $841,000, respectively, were attributable to origination fees on such loans. The loans are
principally secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers.
Interest
and amortization of deferred financing costs
Interest
and amortization of deferred financing costs for the six months ended June 30, 2025 were approximately $958,000 compared to approximately
$1,294,000 for the six months ended June 30, 2024, a decrease of $336,000, or 26.0%. The decrease is primarily attributable to the decrease
in interest expense due to lower SOFR rates and a reduction in borrowed amounts related to the use of the Webster Credit Line (see Note
5 to the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q).
General
and administrative expenses
General
and administrative expenses for the six months ended June 30, 2025 were approximately $891,000 compared to approximately $845,000 for
the six months ended June 30, 2024, an increase of $46,000, or 5.4%. The increase is primarily attributable to increases in payroll and
appraisal expenses as well as NYSE American listing fee, partially offset by reductions in travel and meals expenses as well as costs
related to the filing of our registration statement on Form S-3 incurred in 2024.
Net
income
Net
income for the six months ended June 30, 2025 was approximately $2,786,000 compared to approximately $2,885,000 for the six months ended
June 30, 2024, a decrease of $99,000, or 3.4%. This decrease is primarily attributable to the decrease in interest income from loans,
partially offset by the decrease in interest expense.
Liquidity
and Capital Resources
At
June 30, 2025, we had cash of approximately $209,000, compared to cash of approximately $178,000 at December 31, 2024, not including
restricted cash, which mainly represents collections received, pending clearance, from the Company’s commercial loans and is primarily
dedicated to the reduction of the Webster Credit Line.
For
the six months ended June 30, 2025, net cash provided by operating activities was approximately $2,407,000, compared to approximately
$2,425,000 for the six months ended June 30, 2024. The decrease in net cash provided by operating activities was primarily due to the
decrease in net income and a larger increase in interest and other fees receivable on loans compared to the prior period, partially offset
by an increase in deferred origination and other fees.
For
the six months ended June 30, 2025, net cash provided by investing activities was approximately $136,000, compared to approximately $6,410,000
for the six months ended June 30, 2024. Net cash provided by investing activities for the six months ended June 30, 2025 mainly consisted
of the collection of our commercial loans of approximately $23,619,000, offset by the issuance of commercial loans of approximately $23,483,000.
Net cash provided by investing activities for the six months ended June 30, 2024 mainly consisted of the collection of our commercial
loans of approximately $25,866,000, offset by the issuance of commercial loans of $19,455,000.
For
the six months ended June 30, 2025, net cash used in financing activities was approximately $2,536,000, compared to approximately $10,421,000
for the six months ended June 30, 2024. Net cash used in financing activities for the six months ended June 30, 2025 reflects dividend
payments of approximately $2,631,000, partially offset by the net proceeds from the Webster Credit Line of approximately $95,000. Net
cash used in financing activities for the six months ended June 30, 2024 reflects the partial repayment of the Webster Credit Line of
approximately $7,807,000, dividend payments of approximately $2,603,000, repurchase of treasury shares of approximately $10,000 and deferred
financing costs of approximately $2,000.
Our
Amended and Restated Credit and Security Agreement with Webster, Flushing Bank and Mizrahi provides for the Webster Credit Line. Currently,
the Webster Credit Line provides us with a credit line of $32.5 million in the aggregate until February 28, 2026, secured by assignments
of mortgages and other collateral. The interest rates relating to the Webster Credit Line equal (i) SOFR plus a premium, which rate aggregated
approximately 7.9%, including a 0.5% agency fee, as of June 30, 2025, or (ii) a Base Rate (as defined in the Amended and Restated Credit
Agreement) plus 2.00% and a 0.5% agency fee, as chosen by the Company for each drawdown.
The
Webster Credit Line contains various covenants and restrictions including covenants limiting the amount that the Company can borrow relative
to the value of the underlying collateral, maintaining various financial ratios and limitations on the terms of loans the Company makes
to its customers, limiting the Company’s ability to pay dividends under certain circumstances, and limiting the Company’s
ability to repurchase its common shares, sell assets, engage in mergers or consolidations, grant liens, and enter into transactions with
affiliates. In addition, the Webster Credit Line contains a cross default provision which will deem any default under any indebtedness
owed by us or our subsidiary, MBC Funding II, as a default under the credit line. Under the Amended and Restated Credit Agreement, the
Company may repurchase, redeem or otherwise retire its equity securities in an amount not to exceed ten percent of our annual net income
from the prior fiscal year. Further, the Company may issue up to $20 million in bonds through its subsidiary, of which not more than
$10 million of such bonds may be secured by mortgage notes receivable, and provided that the terms and conditions of such bonds are approved
by Webster, subject to its reasonable discretion. In addition, Mr. Ran has provided a personal guaranty of the potential amounts owed
under the Webster Credit Line, with such guaranty not to exceed the sum of $1,000,000 plus any costs relating to the enforcement of the
personal guaranty.
We
were in compliance with all covenants of the Webster Credit Line, as amended, as of June 30, 2025. At June 30, 2025, the outstanding
amount under the Amended and Restated Credit Agreement was $16,523,205. The interest rate on the amount outstanding fluctuates daily.
The rate, including a 0.5% agency fee, was approximately 7.9% as of June 30, 2025.
MBC
Funding II has $6,000,000 of outstanding principal amount of Notes. The Notes mature on April 22, 2026, unless redeemed earlier, and
accrue interest at a rate of 6% per annum commencing on May 16, 2016 and will be payable monthly, in arrears, in cash, on the 15th day
of each calendar month, commencing June 2016.
Under
the terms of the Indenture, the aggregate outstanding principal balance of the mortgage loans held by MBC Funding II, together with its
cash on hand, must always equal at least 120% of the aggregate outstanding principal amount of the Notes at all times. To the extent
the aggregate principal amount of the mortgage loans owned by MBC Funding II plus its cash on hand is less than 120% of the aggregate
outstanding principal balance of the Notes, MBC Funding II is required to repay, on a monthly basis, the principal amount of the Notes
equal to the amount necessary such that, after giving effect to such repayment, the aggregate principal amount of all mortgage loans
owned by it plus, its cash on hand at such time is equal to or greater than 120% of the outstanding principal amount of the Notes. For
this purpose, each mortgage loan is deemed to have a value equal to its outstanding principal balance, unless the borrower is in default
of its obligations.
The
Notes are secured by a first priority lien on all of MBC Funding II’s assets, including, primarily, mortgage notes, mortgages and
other transaction documents entered into in connection with first mortgage loans originated and funded by us, which MBC Funding II acquired
from MBC pursuant to an asset purchase agreement. MBC Funding II may redeem the Notes, in whole or in part, at any time after April 22,
2019 upon at least 30 days prior written notice to the noteholders. The redemption price will be equal to the outstanding principal amount
of the Notes redeemed plus the accrued but unpaid interest thereon up to, but not including, the date of redemption, without penalty
or premium. No Notes were redeemed by MBC Funding II as of June 30, 2025.
MBC
Funding II is obligated to offer to redeem the Notes if there occurs a “change of control” with respect to us or MBC Funding
II or if we or MBC Funding II sell any assets unless, in the case of an asset sale, the proceeds are reinvested in the business of the
seller. The redemption price in connection with a “change of control” will be 101% of the principal amount of the Notes redeemed
plus accrued but unpaid interest thereon up to, but not including, the date of redemption. The redemption price in connection with an
asset sale will be the outstanding principal amount of the Notes redeemed plus accrued but unpaid interest thereon up to, but not including,
the date of redemption.
We
guarantee MBC Funding II’s obligations under the Notes, which are secured by our pledge of 100% of the outstanding common shares
of MBC Funding II that we own.
On
April 11, 2023, our board of directors authorized a share buyback program for the repurchase of up to 100,000 of our common shares. Before
this program expired on April 10, 2024, we had purchased an aggregate of 56,294 common shares at an aggregate cost of approximately $271,000.
We
expect that our current cash balances, the Amended and Restated Credit Agreement, as described above, and cash flows from operations
will be sufficient to fund our operations over the next 12 months. We currently do not believe there will be any issues in extending
the Webster Credit Line or securing a similar line from another bank before its expiration, and we plan to refinance the Notes prior
to their maturity, though we cannot assure that we will be successful in doing so on favorable terms or at all. From time to time, we
also receive short-term unsecured loans from our executive officers and others, providing us with the flexibility needed for the steady
deployment of capital. However, we anticipate that our working capital requirements will increase in the coming 12 months as we continue
to pursue growth under favorable conditions.
Item
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As
a smaller reporting company, we are not required to provide the information required by this Item.
Item
4. CONTROLS AND PROCEDURES
|
(a) |
Evaluation
and Disclosure Controls and Procedures |
Our
management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure
controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2025 (the “Evaluation
Date”). Based upon that evaluation, the chief executive officer and the chief financial officer concluded that, as of the Evaluation
Date, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that
we file or submit under the Exchange Act (i) are recorded, processed, summarized and reported, within the time periods specified in the
Securities and Exchange Commission’s rules and forms and (ii) are accumulated and communicated to our management, including its
chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
|
(b) |
Changes
in Internal Control Over Financial Reporting
|
There
was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) during
the fiscal quarter ended June 30, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control
over financial reporting.
PART
II OTHER INFORMATION
Item
6. EXHIBITS
Exhibit
No. |
|
Description |
31.1 |
|
Chief Executive Officer Certification under Rule 13a-14 |
31.2 |
|
Chief Financial Officer Certification under Rule 13a-14 |
32.1* |
|
Chief Executive Officer Certification pursuant to 18 U.S.C. section 1350 |
32.2* |
|
Chief Financial Officer Certification pursuant to 18 U.S.C. section 1350 |
101.INS |
|
Inline
XBRL Instance Document |
101.CAL |
|
Inline
XBRL Taxonomy Extension Schema Document |
101.SCH |
|
Inline
XBRL Taxonomy Extension Calculation Linkbase Document |
101.LAB |
|
Inline
XBRL Taxonomy Extension Label Linkbase Document |
101.PRE |
|
Inline
XBRL Taxonomy Extension Presentation Linkbase Document |
101.DEF |
|
Inline
XBRL Taxonomy Extension Definition Linkbase Document |
104 |
|
Cover
Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101). |
* |
Furnished,
not filed, in accordance with item 601(32)(ii) of Regulation S-K. |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
Manhattan Bridge Capital, Inc. (Registrant) |
|
|
|
Date:
July 22, 2025 |
By: |
/s/
Assaf Ran |
|
|
Assaf
Ran, President and Chief Executive Officer |
|
|
(Principal
Executive Officer) |
|
|
|
Date:
July 22, 2025 |
By:
|
/s/
Vanessa Kao |
|
|
Vanessa
Kao, Chief Financial Officer |
|
|
(Principal
Financial and Accounting Officer) |